Aktuell 24 mai 2024 Geistlich erhält EU-Zertifizierung für Kollagen-Portfolio Geistlich Pharma hat die MDR-Zertifizierung für seine Kollagen-Produktpalette erhalten und erfüllt damit die neuen EU-Vorschriften. Die Produkte ...
News 24 mai 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News 13 mar 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
Actualités 12 jan 2022 ObsEva obtient des résultats positifs dans le traitement de l’endométriose Spécialisée dans la santé des femmes, la société biopharmaceutique genevoise ObsEva a annoncé des résultats préliminaires positifs de l'essai de ...
News 12 jan 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
News 29 jan 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 05 mai 2023 Alentis raises 105 million US dollars Alentis Therapeutics has received 105 million US dollars in a series C funding round. It will invest the funds in the phase I and II programs for...
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Aktuell 05 mai 2023 Alentis nimmt 105 Millionen Dollar ein Alentis Therapeutics hat in einer Finanzierungsrunde der Serie C 105 Millionen Dollar erhalten. Sie werden in die Phase I- und Phase II-Programme...
News 10 nov 2023 Researchers heal wounds with lactobacilli Researchers from Switzerland and the USA have jointly developed a dressing that uses probiotics to eliminate pathogens in chronic wounds. The pro...
News 18 out 2022 KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based start-up develops products to alleviate neurological disease...
News 20 out 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
Aktuell 18 out 2022 KetoSwiss erhöht Kapital um 4 Millionen Dollar KetoSwiss hat von Investoren 4 Millionen Dollar erhalten. Das Basler Start-up entwickelt Produkte zur Linderung neurologischer Erkankungen wie Mi...
News 17 abr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 11 mai 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...
News 18 jul 2023 AI uncovers drug to treat rare pediatric disease The University of Zurich has identified a way to help children suffering from cystinosis in partnership with Insilico Medicine and the company’s ...
News 27 nov 2020 Dottikon ES to build new production plant Dottikon ES is building a new chemical production plant for pharmaceutical active ingredients. To achieve this, an investment in the amount of 27...
News 14 ago 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.